Safety of Cyproheptadine, an Orexigenic Drug. Analysis of the French National Pharmacovigilance Data-Base and Systematic Review

Objectives: Cyproheptadine is a first-generation H1-antihistamine drug first that was distributed in the 1960s. While its orexigenic effect was observed early, cyproheptadine is not yet authorized for this indication in all countries today. There is an increasing medical interest and demand for the...

Descripción completa

Detalles Bibliográficos
Autores principales: Bertrand, Valérie, Massy, Nathalie, Vegas, Nancy, Gras, Valérie, Chalouhi, Christel, Tavolacci, Marie-Pierre, Abadie, Véronique
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pediatrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8525494/
https://www.ncbi.nlm.nih.gov/pubmed/34676184
http://dx.doi.org/10.3389/fped.2021.712413

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8525494/
https://www.ncbi.nlm.nih.gov/pubmed/34676184
http://dx.doi.org/10.3389/fped.2021.712413

Ejemplares similares